Embecta Operating Margin 2021-2025 | EMBC
Current and historical operating margin for Embecta (EMBC) over the last 10 years. The current operating profit margin for Embecta as of March 31, 2025 is 13.70%.
| Embecta Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $1.08B | $0.17B | 16.11% |
| 2024-12-31 | $1.11B | $0.15B | 13.54% |
| 2024-09-30 | $1.12B | $0.17B | 14.87% |
| 2024-06-30 | $1.12B | $0.17B | 14.92% |
| 2024-03-31 | $1.13B | $0.16B | 14.31% |
| 2023-12-31 | $1.12B | $0.18B | 15.95% |
| 2023-09-30 | $1.12B | $0.22B | 19.80% |
| 2023-06-30 | $1.11B | $0.19B | 17.32% |
| 2023-03-31 | $1.12B | $0.24B | 21.36% |
| 2022-12-31 | $1.12B | $0.28B | 25.25% |
| 2022-09-30 | $1.13B | $0.31B | 27.43% |
| 2022-06-30 | $1.16B | $0.43B | 37.20% |
| 2022-03-31 | $1.16B | $0.46B | 39.40% |
| 2021-12-31 | $1.17B | $0.48B | 41.40% |
| 2021-09-30 | $1.17B | $0.49B | 42.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.605B | $1.123B |
| Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.129B | 26.36 |
| CVS Health (CVS) | United States | $80.640B | 10.03 |
| Elevance Health (ELV) | United States | $63.834B | 8.59 |
| Cencora (COR) | United States | $53.960B | 17.97 |
| DiDi Global (DIDIY) | China | $27.015B | 28.70 |
| Labcorp Holdings (LH) | United States | $21.603B | 17.17 |
| Natera (NTRA) | United States | $19.264B | 0.00 |
| BioMerieux (BMXMF) | France | $17.067B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.705B | 0.00 |
| CochLear (CHEOY) | Australia | $13.281B | 0.00 |
| ICON (ICLR) | Ireland | $12.747B | 12.27 |
| Solventum (SOLV) | United States | $12.448B | 12.87 |
| Medpace Holdings (MEDP) | United States | $12.046B | 31.88 |
| Viatris (VTRS) | United States | $11.021B | 3.90 |
| Revvity (RVTY) | United States | $10.036B | 17.68 |
| Sonic Healthcare (SKHHY) | Australia | $8.936B | 0.00 |
| HealthEquity (HQY) | United States | $7.942B | 34.79 |
| Avantor (AVTR) | United States | $7.758B | 11.38 |
| Charles River Laboratories (CRL) | United States | $7.371B | 13.98 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.273B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.885B | 32.86 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.624B | 27.65 |
| Sotera Health (SHC) | United States | $3.185B | 18.10 |
| GeneDx Holdings (WGS) | United States | $3.023B | 69.70 |
| Surgery Partners (SGRY) | United States | $2.977B | 37.45 |
| Alignment Healthcare (ALHC) | United States | $2.745B | 0.00 |
| Concentras Parent (CON) | United States | $2.589B | 16.42 |
| Organon (OGN) | United States | $2.368B | 2.58 |
| Progyny (PGNY) | United States | $1.977B | 41.93 |
| Premier (PINC) | United States | $1.848B | 14.02 |
| PACS (PACS) | United States | $1.690B | 0.00 |
| Ardent Health (ARDT) | United States | $1.641B | 6.34 |
| Pediatrix Medical (MD) | United States | $1.261B | 8.42 |
| GoodRx Holdings (GDRX) | United States | $1.239B | 20.41 |
| Teladoc Health (TDOC) | United States | $1.228B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.040B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.656B | 225.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.648B | 8.02 |
| CareDx (CDNA) | United States | $0.642B | 11.83 |
| Performant Healthcare (PHLT) | United States | $0.597B | 0.00 |
| Omada Health (OMDA) | $0.501B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.496B | 7.50 |
| So-Young (SY) | China | $0.490B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
| Sonida Senior Living (SNDA) | United States | $0.458B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.441B | 0.00 |
| SBC Medicals (SBC) | United States | $0.438B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.395B | 26.00 |
| Oncology Institute (TOI) | United States | $0.371B | 0.00 |
| Agilon Health (AGL) | United States | $0.363B | 0.00 |
| LifeMD (LFMD) | United States | $0.313B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.098B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.095B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| KindlyMD (NAKA) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |